BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 17722021)

  • 1. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia.
    Rigatelli G; Cardaioli P; Braggion G; Giordan M; Fabio D; Aggio S; Roncon L; Chinaglia M
    Catheter Cardiovasc Interv; 2007 Sep; 70(3):429-33. PubMed ID: 17722021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting.
    Giardini A; Donti A; Formigari R; Salomone L; Prandstraller D; Bonvicini M; Palareti G; Guidetti D; Gaddi O; Picchio FM
    Am Heart J; 2006 Apr; 151(4):922.e1-5. PubMed ID: 16569564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale.
    Rodés-Cabau J; Mineau S; Marrero A; Houde C; Mackey A; Côté JM; Chetaille P; Delisle G; Bertrand OF; Rivest D
    Am J Cardiol; 2008 Mar; 101(5):688-92. PubMed ID: 18308022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter patent foramen ovale closure in spite of interatrial septum hypertrophy or lipomatosis: a case series.
    Rigatelli G; Dell'Avvocata F; Giordan M; Ronco F; Braggion G; Schenal N; Aggio S; Cardaioli P
    J Cardiovasc Med (Hagerstown); 2010 Feb; 11(2):91-5. PubMed ID: 19829139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experience.
    Ussia GP; Cammalleri V; Mulè M; Scarabelli M; Barbanti M; Scardaci F; Mangiafico S; Immè S; Capodanno D; Tamburino C
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):607-14. PubMed ID: 19360875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and long-term results of patent foramen ovale transcatheter closure in patients with thrombophilia.
    Rigatelli G; Dell'Avvocata F; Giordan M; Camerotto A; Panin S; Ronco F; Cardaioli P
    Minerva Cardioangiol; 2009 Jun; 57(3):285-9. PubMed ID: 19513009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter patent foramen ovale closure using the Premere PFO occlusion system.
    Donti A; Giardini A; Salomone L; Formigari R; Picchio FM
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):736-40. PubMed ID: 17039524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
    Chatterjee T; Petzsch M; Ince H; Rehders TC; Körber T; Weber F; Schneider H; Auf der Maur C; Nienaber CA
    J Interv Cardiol; 2005 Jun; 18(3):173-9. PubMed ID: 15966921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
    Spies C; Timmermanns I; Reissmann U; van Essen J; Schräder R
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):390-5. PubMed ID: 18288745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Migraine headache relief after transcatheter closure of patent foramen ovale.
    Reisman M; Christofferson RD; Jesurum J; Olsen JV; Spencer MP; Krabill KA; Diehl L; Aurora S; Gray WA
    J Am Coll Cardiol; 2005 Feb; 45(4):493-5. PubMed ID: 15708692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism.
    Rigatelli G; Dell'Avvocata F; Ronco F; Cardaioli P; Giordan M; Braggion G; Aggio S; Chinaglia M; Rigatelli G; Chen JP
    JACC Cardiovasc Interv; 2010 Mar; 3(3):282-7. PubMed ID: 20298985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premere occlusion system for transcatheter patent foramen ovale closure: mid-term results of a single-center registry.
    Rigatelli G; Cardaioli P; Dell'avvocata F; Giordan M; Chinaglia M
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):564-9. PubMed ID: 20602480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of interatrial shunts and migraine headaches: impact of transcatheter closure.
    Azarbal B; Tobis J; Suh W; Chan V; Dao C; Gaster R
    J Am Coll Cardiol; 2005 Feb; 45(4):489-92. PubMed ID: 15708691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right-to-left shunt and instrumental evidence of cerebrovascular damage.
    Papa M; Gaspardone A; Fragasso G; Ajello S; Gioffrè G; Iamele M; Iani C; Margonato A
    Am J Cardiol; 2009 Aug; 104(3):434-9. PubMed ID: 19616680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial experience with a transcatheter septal closure system for secondary stroke prevention in patients with interatrial septal defects.
    Silverman IE; Kiernan FJ; Kelsey AM; Brakoniecki JJ; Kazi FA; Dougherty JE; Boden WE; McKay RG
    Conn Med; 2003 Mar; 67(3):135-44. PubMed ID: 12687787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ICE-guided patent foramen ovale (PFO) closure with lastest-generation devices: the ideal strategy for PFO-related migraine?
    Rigatelli G; Cardaioli P; Braggion G; Giordan M; Aggio S; Roncon L
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):633-5. PubMed ID: 17667037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and brain magnetic resonance imaging follow-up after percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
    Vigna C; Inchingolo V; Giannatempo G; Pacilli MA; Di Viesti P; Fusilli S; Amico CM; Santoro T; Lanna P; Fanelli R; Simone P; Loperfido F
    Am J Cardiol; 2008 Apr; 101(7):1051-5. PubMed ID: 18359330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter closure of patent foramen ovale with the Spider patent foramen ovale occluder: a prospective, single-center trial.
    Zhang CJ; Huang YG; Huang XS; Huang T; Huang WH; Shen JJ; Xun ZR
    Chin Med J (Engl); 2010 Apr; 123(7):834-7. PubMed ID: 20497673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent foramen ovale closure in patients with cryptogenic thrombo-embolic events using the Cardia PFO occluder.
    Spies C; Strasheim R; Timmermanns I; Schraeder R
    Eur Heart J; 2006 Feb; 27(3):365-71. PubMed ID: 16254007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter intracardiac echocardiography-assisted closure of interatrial shunts: complications and midterm follow-up.
    Rigatelli G; Cardaioli P; Giordan M; Dell'Avvocata F; Braggion G; Piergentili C; Roncon L; Faggian G
    Echocardiography; 2009 Feb; 26(2):196-202. PubMed ID: 19207996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.